Epilepsy and schizophrenia: relationship and biochemistry (Q39876738)

15 September 2017

1 reference

title

Epilepsy and schizophrenia: relationship and biochemistry (English)

1 reference

15 September 2017

0 references

E H Reynolds

1

1 reference

PubMed ID

4169979

15 September 2017

language of work or name

English

0 references

publication date

1 February 1968

1 reference

15 September 2017

1 reference

15 September 2017

1

1 reference

15 September 2017

7539

1 reference

15 September 2017

398-401

1 reference

REPORT of World Health Organization Study Group on Schizophrenia-Geneva, September 9-14, 1957

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

The schizophrenialike psychoses of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Anticonvulsant Therapy, Folic Acid and Vitamin B12 Metabolism and Mental Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Schizophrenia-like Psychoses of Epilepsy and Disturbances of Folate and Vitamin B12Metabolism Induced by Anticonvulsant Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Lactobacillus casei C.S.F. folate activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Neuropsychiatric aspects of anticonvulsant megaloblastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Personality changes following temporal lobectomy for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Statistical study of clinical and electroencephalographic manifestations of 536 psychotic episodes occurring in 516 epileptics between clinical seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure disch

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

BIOLOGICAL ASPECTS OF ELECTROCONCLUSIVE THERAPY.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

PRESENT TREATMENT OF SCHIZOPHRENIA--A CONTROLLED FOLLOW-UP STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Effects of amino acid feedings in schizophrenic patients treated with iproniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Effects of methionine loading on the behavior of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Reversible behavioral and electrographic manifestations induced by methionine sulfoximine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

D,L-Methionine-d, l-Sulfoximine Effects in Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Schizophrenia: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Isolation and Characterization of a Compound from the Urine of Schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

‘Pink Spot’ in the Urine of Schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

HOMOCYSTINURIA: A NEW INBORN ERROR OF METABOLISM ASSOCIATED WITH MENTAL DEFICIENCY.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Schizophrenia in a patient with a defect in methionine metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Schizophrenia-melanosis: cause or side-effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

THE FUNCTION OF VITAMIN B12 AND FOLIC ACID COENZYMES IN MAMMALIAN CELLS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Metabolism of epinephrine and other sympathomimetic amines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

Vitamin B12 and Folate Deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2868%2991359-7

7 January 2021

10.1016/S0140-6736(68)91359-7

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

4169979